IDO1 and leukemia: IDO signaling—Tregs induced by IDO-expressing leukemic DCs impair leukemia-specific CTL (103).Increased IDO activity—lower CR rates and shorter OS in AML (103–105).Blocking of IDO—effective immune response in AML in vitro (103–106).